Novartis Hit With $250K Verdict In Zometa Jaw Injury Suit

Law360, New York (March 4, 2013, 8:00 PM EST) -- A Florida jury slapped Novartis Pharmaceuticals Corp. with a $250,000 verdict on Wednesday in multidistrict litigation over injuries allegedly caused by the bone drug Zometa, though it declined to impose punitive damages on the drugmaker.

The plaintiff, Florida resident J. Hunter Chiles, claimed that Novartis failed to warn that Zometa, a bisphosphonate he took to treat his multiple myeloma, could cause the bone disease osteonecrosis of the jaw. The suit is part of the multidistrict litigation targeting Zometa and an older Novartis bone drug, Aredia....
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Chiles v. Novartis Pharmaceuticals Corporation


Case Number

3:06-cv-00096

Court

Florida Middle

Nature of Suit

Personal Inj. Prod. Liability

Judge

Henry Lee Adams, Jr

Date Filed

January 31, 2006

Law Firms

Companies

Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.